Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 4,095 4,435 11,239 10,971
General and administrative 2,021 1,659 6,394 5,122
Depreciation and amortization 41 57 130 154
Total operating expenses 6,157 6,151 17,763 16,247
Loss from operations (6,157) (6,151) (17,763) (16,247)
Other income:        
Gain from change in fair value of warrant liability 1,678 2,743 4,428 1,489
Other income, net 13 10 30 32
Interest income, net 87 3 236 10
Net loss $ (4,379) $ (3,395) $ (13,069) $ (14,716)
Net loss per common share - basic and diluted (in dollars per share) $ (0.15) $ (0.33) $ (0.50) $ (1.55)
Weighted average common shares outstanding, basic and diluted (in shares) 28,573,476 10,245,810 26,302,638 9,496,585
Net loss $ (4,379) $ (3,395) $ (13,069) $ (14,716)
Other comprehensive income (loss):        
Foreign currency translation (16) 10 (26) 2
Comprehensive loss $ (4,395) $ (3,385) $ (13,095) $ (14,714)